ArticleAnnals of the American Thoracic Society2025
Phenotypes and Trajectories of Tobacco-exposed Persons with Preserved Spirometry: Insights from Lung Volumes.
Abstract read
In one paragraph
Article in Annals of the American Thoracic Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Definitions of early COPD and predictors for disease progression: a systematic review.European respiratory review : an official journal of the European Respiratory Society · 2026Pooled it
- Plasma proteomic profiles of lung volume-based phenotypes in tobacco-exposed individuals without spirometric chronic obstructive pulmonary disease.Annals of the American Thoracic Society · 2026Observational
- New approaches to uncover COPD pathobiology and develop therapies.JCI insight · 2026Review
- Resting lung volume phenotypes in COPD: implications for exertional dyspnoea and exercise tolerance.ERJ open research · 2025Article
- Lung Volumes in Smokers without Chronic Obstructive Pulmonary Disease: A Pointer to Disease Development?Annals of the American Thoracic Society · 2025Article
Corrections and comments
- Commented on by
Authors and funding
26 authors.
Mehrdad ArjomandiMedical Service, San Francisco Veterans Affairs Healthcare System, San Francisco, California.ORCID 0000-0002-0116-9217
Siyang ZengMedical Service, San Francisco Veterans Affairs Healthcare System, San Francisco, California.ORCID 0000-0001-9346-301X
Igor BarjaktarevicDivision of Pulmonary and Critical Care Medicine, University of California, Los Angeles, California.
Eugene R BleeckerDivision of Respiratory Medicine, Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona.
Russell P BowlerDepartment of Systems Biology & Genome Sciences, Cleveland Clinic, Cleveland, Ohio.ORCID 0000-0003-4651-363X
Gerard J CrinerDepartment of Thoracic Medicine and Surgery, Temple University, Philadelphia, Pennsylvania.
Alejandro P ComellasDepartment of Internal Medicine, and.ORCID 0000-0003-1521-7520
David J CouperDepartment of Biostatistics, University of North Carolina, Chapel Hill, North Carolina.
Jeffrey L CurtisDivision of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-5191-4847
Mark T DransfieldDivision of Pulmonary, Allergy, & Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
M Bradley DrummondDepartment of Biostatistics, University of North Carolina, Chapel Hill, North Carolina.ORCID 0000-0002-6968-4610
Spyridon FortisDepartment of Internal Medicine, and.ORCID 0000-0001-7807-6740
MeiLan K HanDivision of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan.
Nadia N HanselDivision of Pulmonary and Critical Care Medicine, Johns Hopkins Medical Institute, Baltimore, Maryland.
Eric A HoffmanDepartment of Internal Medicine, and.ORCID 0000-0001-8456-9437
Robert J KanerDivision of Pulmonary and Critical Care Medicine, Weill Cornell Medical Center, New York, New York.
Richard E KannerDivision of Pulmonary and Critical Care Medicine, University of Utah, Salt Lake City, Utah.
Jerry A KrishnanDivision of Pulmonary, Critical Care, Sleep, and Allergy, University of Illinois at Chicago, Chicago, Illinois.ORCID 0000-0001-5525-4778
Wassim LabakiDivision of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan.
Victor E OrtegaDivision of Respiratory Medicine, Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona.
Stephen P PetersSection on Pulmonary, Critical Care, Allergy & Immunologic Diseases, Wake Forest School of Medicine, Winston-Salem, North Carolina; and.
Stephen I RennardSection on Pulmonary and Critical Care Medicine, University of Nebraska Medical Center, Omaha, Nebraska.
Christopher B CooperDivision of Pulmonary and Critical Care Medicine, University of California, Los Angeles, California.
Donald P TashkinDivision of Pulmonary and Critical Care Medicine, University of California, Los Angeles, California.
Robert PaineDivision of Pulmonary and Critical Care Medicine, University of Utah, Salt Lake City, Utah.
Prescott G WoodruffDivision of Pulmonary, Critical Care, Allergy, and Sleep Medicine, University of California, San Francisco, California.
Funding
Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI HANS-JOACHIM LEHMLER · 1990 to 2026
$40.5MSPIROMICS II: Biological underpinnings of COPD heterogeneity and progressionU01HL137880 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WOODRUFF, PRESCOTT G · 2017 to 2021
$27.9MUniversity of Washington Biomedical Informatics and Data Science Research Training ProgramT15LM007442 · NLM · UNIVERSITY OF WASHINGTON · PI JOHN H. GENNARI, Andrea L. Hartzler · 2002 to 2026
$19.6MUnderstanding the Origins of Early COPDR01HL144718 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI CURTIS, JEFFREY LOUIS, HAN, MEILAN K · 2020 to 2024
$11.3MSPIROMICS GIC SupportU24HL141762 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COUPER, DAVID J, O'NEAL, WANDA K · 2018 to 2022
$7.2MMentoring Research in Precision Medicine for Lung DiseaseK24HL137013 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PRESCOTT G WOODRUFF · 2017 to 2026
$1.2MFlight Attendant Medical Research Institute CIA190001NHLBI NIH HHS HHSN268200900013CNHLBI NIH HHS HHSN268200900014CNHLBI NIH HHS K24 HL137013NHLBI NIH HHS R01 HL144718NHLBI NIH HHS U01 HL137880NHLBI NIH HHS U24 HL141762NIEHS NIH HHS P30 ES005605NLM NIH HHS T15 LM007442Tobacco-Related Disease Research Program T29IR0715U.S. National Library of Medicine T15LM007442
Abstract
PubMed holds no abstract for this paper.
Indexed as
LungPulmonary Disease, Chronic ObstructivePulmonary EmphysemaSmokingAgedDisease ProgressionFemaleForced Expiratory VolumeFunctional Residual CapacityHumansLung Volume MeasurementsMaleMiddle AgedPhenotypeSpirometryTomography, X-Ray Computedair trappingCOPDlung volumespre-COPDsmoking
Identifiers
What Socratic holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.